1.
J Clin Ethics
; 32(3): 206-214, 2021.
Article
in English
| MEDLINE
| ID: mdl-34548429
ABSTRACT
In this article, we analyze the ethics of elective growth hormone (GH) therapy in children with idiopathic short stature (ISS). We discuss recent clinical research regarding the efficacy, side-effects, and risks of GH therapy, and argue that GH therapy is ethically unjustifiable for most children with ISS.
